Is modulation of nicotinic acetylcholine receptors by melatonin relevant for therapy with cholinergic drugs?
about
Melatonin therapy for REM sleep behavior disorder: a critical review of evidenceMelatoninergic System in Parkinson's Disease: From Neuroprotection to the Management of Motor and Nonmotor SymptomsAdd-on prolonged-release melatonin for cognitive function and sleep in mild to moderate Alzheimer's disease: a 6-month, randomized, placebo-controlled, multicenter trial.Adjunctive treatment with melatonin receptor agonists for older delirious patients with the sundowning phenomenon.Postpartum depression: psychoneuroimmunological underpinnings and treatment.Protective effects of an interaction between vagus nerve and melatonin on gastric ischemia/reperfusion: the role of oxidative stress.Redox Regulation and the Autistic Spectrum: Role of Tryptophan Catabolites, Immuno-inflammation, Autoimmunity and the Amygdala.Exercise and melatonin in humans: reciprocal benefits.Psychoneuroendocrine interventions aimed at attenuating immunosenescence: a review.Biological phenotypes underpin the physio-somatic symptoms of somatization, depression, and chronic fatigue syndrome.Ebola virus: melatonin as a readily available treatment option.Interactions of Tryptophan and Its Catabolites With Melatonin and the Alpha 7 Nicotinic Receptor in Central Nervous System and Psychiatric Disorders: Role of the Aryl Hydrocarbon Receptor and Direct Mitochondria Regulation.Morphofunctional and signaling molecules overlap of the pineal gland and thymus: role and significance in aging.Melatonin inhibits alcohol-induced increases in duodenal mucosal permeability in rats in vivo.Impact of the Gut Microbiota on Intestinal Immunity Mediated by Tryptophan Metabolism.
P2860
Q26825314-884C4949-D1C6-4E3A-8777-F3EFEFC1570BQ28075345-522DE680-7AA6-4CA0-B45A-30426FDC6731Q33800161-5E641194-E08D-4B27-BD4C-ADE2613D2F58Q35162815-85F4C8A1-6B56-4E06-95CC-EE696267646EQ36639113-68696306-B20C-490E-8A53-FD270B83D296Q36773818-A20086B5-CA32-4D66-B15F-EE154D74D5E4Q37661363-104B86DF-BFF4-4306-B09F-267D3EDC8DA7Q37919169-16D5934E-F875-452E-8CB3-7BFD6C7B5991Q38071251-1D975583-334E-4266-AA47-E14DD3AB319DQ38129457-7B65B130-F26B-49EB-B5F6-01A9C8B3913BQ38328156-846AC133-B05F-4BF5-BBBE-DC62A187C5EAQ39281814-91396DAD-9EDE-404D-934F-4EF93C7D31BCQ39948155-D47CC3EC-60A6-4568-8FB7-CE756D31ED1BQ44900972-3E2B56BB-7BDA-4182-BF9D-00104F57374FQ50223024-7454C2F7-4447-4294-9ACD-65F29291DF8E
P2860
Is modulation of nicotinic acetylcholine receptors by melatonin relevant for therapy with cholinergic drugs?
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 14 April 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Is modulation of nicotinic ace ...... herapy with cholinergic drugs?
@en
Is modulation of nicotinic ace ...... herapy with cholinergic drugs?
@nl
type
label
Is modulation of nicotinic ace ...... herapy with cholinergic drugs?
@en
Is modulation of nicotinic ace ...... herapy with cholinergic drugs?
@nl
prefLabel
Is modulation of nicotinic ace ...... herapy with cholinergic drugs?
@en
Is modulation of nicotinic ace ...... herapy with cholinergic drugs?
@nl
P2093
P1476
Is modulation of nicotinic ace ...... herapy with cholinergic drugs?
@en
P2093
Claudia L M Silva
Daiane Gil Franco
Eduardo Mortani Barbosa
P304
P356
10.1016/J.PHARMTHERA.2010.02.009
P577
2010-04-14T00:00:00Z